Jason Watts

Jason Watts

Jason Watts is a partner in the Sydney office of King & Wood Mallesons where he specialises in mergers & acquisitions, focusing on public company and privately negotiated transactions and private equity. He regularly advises on general corporate law, securities law and governance issues. He is a relationship partner for a number of the firm's key clients.

Recent matters

  • Veda in its privatisation by PEP
  • CVC in its acquisition of a 75% interest in PBL's media assets
  • CSR in its $480 million accelerated rights issues
  • Westfield in its $2.9 billion placement
  • Primary Healthcare in its hostile take over of Symbion Health and subsequent divestments
  • ASX in its merger with SFE
  • Westfield in its stapling to create the Westfield Group.

Show moreShow less

Memberships

  • Law Society of New South Wales
  • Business Law Section - Law Council of Australia.

Experience

  • 1988: Bachelor of Economics degree, University of Sydney
  • 1990: Bachelor of Laws degree, University of Sydney (First Class Honours)
  • 1992 - 1997: Solicitor, Mallesons Stephen Jaques, Sydney
  • 1997 - 1999: Senior Associate, Mallesons Stephen Jaques, Sydney
  • 1999 - 2002: Manager, Strategic Development - Fairfax Digital
  • 2002 - 2003: Senior Associate, Mallesons Stephen Jaques, Sydney
  • 2004 - present: Partner, King & Wood Mallesons, Sydney.

Location

Legal insights

While forms of modern slavery are criminalised under the Criminal Code Act 1995 (Cth), the introduction of a regime similar to the UK Act would have implications for company boards.

07 August 2017

There are unique legal tensions as investors look to sell their fund commitments with relative freedom and general partners/managers seek to minimise their potential liabilities.

15 March 2017

W&I Insurance can have significant benefits by reducing seller risks, enabling cleaner exits, narrowing the range of commercial issues and potentially expediting transactions.

02 March 2017

The new ASIC Corporations (Wholly-owned Companies) Instrument 2016/785 applies in relation to a financial year ending on or after 1 January 2017.

27 October 2016